Christina Rossi
About Christina Rossi
Christina Rossi is a seasoned biopharmaceutical executive with extensive experience in commercial strategy and leadership, particularly in the Multiple Sclerosis market.
Education and Expertise
Christina Rossi holds a B.S. in biology, cum laude, from Duke University and an MBA from Harvard Business School. Her combined expertise in biology and business provides a unique perspective that has proven beneficial in her extensive career within the biotech and pharmaceutical industry.
Blueprint Chief Commercial Officer
Christina Rossi has served as the chief commercial officer of Blueprint since October 2018. In this role, she is responsible for overseeing the company's commercial strategies, amplifying Blueprint's market presence, and driving revenue growth through effective product and service offerings.
Sanofi Genzyme Roles and Responsibilities
From January 2015 to October 2018, Christina Rossi was the Multiple Sclerosis business unit head, North America, at Sanofi Genzyme. Prior to this role, she was vice president of Multiple Sclerosis Sales from May 2014 to December 2015 and vice president of Multiple Sclerosis Patient and Provider Services from June 2012 to May 2014. Her roles at Sanofi Genzyme revolved around strategic planning, enhancing product reach, and improving patient and provider services within the multiple sclerosis segment.
Biogen Career Highlights
Christina Rossi held several key positions at Biogen, including head of commercial strategy for Eidetica Biopharma GmbH, Biogen's biosimilar-focused venture, and U.S. brand leader for TYSABRI (natalizumab). Her responsibilities included developing commercial strategies and overseeing brand management to optimize product performance and market penetration.
Consulting Experience at Boston Consulting Group
Christina Rossi's professional journey also includes consulting in the healthcare practice at the Boston Consulting Group. This experience provided her with a broader understanding of strategic healthcare management and allowed her to develop customized solutions tailored to clients' needs within the industry.